Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from BioHarvest Sciences ( (BHST) ) is now available.
BioHarvest Sciences Inc. announced it will release its second quarter 2025 financial results on August 11, 2025, followed by an investor conference call to discuss the results and provide a corporate update. This announcement is significant for stakeholders as it provides insights into the company’s financial health and strategic direction, potentially impacting its market positioning and investor relations.
The most recent analyst rating on (BHST) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on BioHarvest Sciences stock, see the BHST Stock Forecast page.
Spark’s Take on BHST Stock
According to Spark, TipRanks’ AI Analyst, BHST is a Neutral.
BioHarvest Sciences shows robust revenue growth and positive momentum but is hindered by financial instability and unprofitability. The strong earnings call reflects strategic growth initiatives, partially offsetting financial risks. Technical indicators suggest positive momentum, but valuation concerns persist due to negative earnings.
To see Spark’s full report on BHST stock, click here.
More about BioHarvest Sciences
BioHarvest Sciences Inc. is a leader in Botanical Synthesis, utilizing its patented technology to grow plant-based compounds without cultivating the actual plants. The company operates in two main business areas: as a contract development and production organization for novel plant-based compounds and as a creator of proprietary nutraceutical health and wellness products, including dietary supplements.
Average Trading Volume: 9,422
Technical Sentiment Signal: Buy
Current Market Cap: $133.2M
For a thorough assessment of BHST stock, go to TipRanks’ Stock Analysis page.